icatibant
Generic: icatibant
Labeler: eugia us llcDrug Facts
Product Profile
Brand Name
icatibant
Generic Name
icatibant
Labeler
eugia us llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
icatibant acetate 30 mg/3mL
Manufacturer
Identifiers & Regulatory
Product NDC
55150-351
Product ID
55150-351_ff0f66d4-bb7c-43a6-9475-f8d87f21abb4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213521
Listing Expiration
2026-12-31
Marketing Start
2023-08-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55150351
Hyphenated Format
55150-351
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
icatibant (source: ndc)
Generic Name
icatibant (source: ndc)
Application Number
ANDA213521 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/3mL
Packaging
- 1 SYRINGE, GLASS in 1 CARTON (55150-351-01) / 3 mL in 1 SYRINGE, GLASS
- 3 CARTON in 1 CARTON (55150-351-03) / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "ff0f66d4-bb7c-43a6-9475-f8d87f21abb4", "openfda": {"upc": ["0355150351015"], "unii": ["325O8467XK"], "rxcui": ["1148141"], "spl_set_id": ["56d5047e-3f99-4100-af4f-388870986ced"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (55150-351-01) / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "55150-351-01", "marketing_start_date": "20230814"}, {"sample": false, "description": "3 CARTON in 1 CARTON (55150-351-03) / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "55150-351-03", "marketing_start_date": "20230814"}], "brand_name": "Icatibant", "product_id": "55150-351_ff0f66d4-bb7c-43a6-9475-f8d87f21abb4", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "55150-351", "generic_name": "Icatibant", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Icatibant", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "30 mg/3mL"}], "application_number": "ANDA213521", "marketing_category": "ANDA", "marketing_start_date": "20230814", "listing_expiration_date": "20261231"}